- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07655830
Metabolic and Clinical Effects of Hyperchloremia During HoLEP Surgery.
June 13, 2026 updated by: Betül Güven, Ankara City Hospital Bilkent
Evaluation of the Metabolic and Clinical Effects of Intraoperative Hyperchloremia in Holmium Laser Enucleation of Prostate (HoLEP) Surgery.
This study aims to evaluate the changes between preoperative and postoperative serum chloride levels in patients undergoing HoLEP surgery and to investigate the metabolic and clinical effects of this change.
The study is observational, and no additional interventions will be performed.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
Although isotonic irrigation fluids used in HoLEP surgery reduce the risk of hyponatremia associated with TUR syndrome, high-volume fluid absorption may lead to hyperchloremia and subsequent metabolic acidosis.
This prospective, observational, single-center study, conducted at Ankara Bilkent City Hospital, aims to identify early markers of this condition to optimize perioperative management.
Study Type
Observational
Enrollment (Estimated)
45
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Patients scheduled for elective HoLEP surgery.
Description
Inclusion Criteria:
- Patients scheduled for elective HoLEP surgery.
- Patients providing written informed consent
Exclusion Criteria:
- Preoperative metabolic acidosis.
- Advanced renal failure.
- Emergency surgery.
- Missing data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients undergoing elective HoLEP surgery.
|
All parameters are part of routine clinical practice; no additional examinations are required
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in serum chloride level
Time Frame: Perioperative
|
Perioperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
irrigation volume
Time Frame: Perioperative
|
Perioperative
|
|
Arter blood gas
Time Frame: Perioperative
|
Perioperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 4, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Study Registration Dates
First Submitted
June 5, 2026
First Submitted That Met QC Criteria
June 13, 2026
First Posted (Actual)
June 18, 2026
Study Record Updates
Last Update Posted (Actual)
June 18, 2026
Last Update Submitted That Met QC Criteria
June 13, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- TABED1-26-2505
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperchloremia
-
Capital Medical UniversityNot yet recruitingHemorrhagic Stroke | Critical Care | HyperchloremiaChina
-
Capital Medical UniversityCompletedAneurysmal Subarachnoid Hemorrhage | HyperchloremiaChina
-
Karolinska InstitutetCompletedAcute Kidney Injury | Pulmonary Hypertension | Congenital Diaphragmatic Hernia | Multiple Organ Failure | HyperchloremiaSweden
Clinical Trials on HoLEP surgery
-
Ankara City Hospital BilkentNot yet recruitingDriving Pressure | Lung Protective Ventilation | Holmium Laser Enucleation of the ProstateTurkey (Türkiye)
-
University of Kansas Medical CenterCompleted
-
GCS Ramsay Santé pour l'Enseignement et la RechercheTerminated
-
Thunder Bay Regional Health Research InstituteNorthern Ontario School of MedicineActive, not recruitingLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaCanada
-
Marcelino RiveraIndiana UniversityWithdrawn
-
Mansoura UniversityCompleted
-
Northwestern UniversityRecruitingUrologic Diseases | Prostate ObstructionUnited States
-
Olympus Surgical Technologies EuropeTerminatedBenign Prostatic HypertrophyChina
-
Ain Shams UniversityCompletedBenign Prostatic HyperplasiaEgypt
-
University of BariGaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaboratorsUnknownBenign Prostatic Hyperplasia (BPH)Italy